Magnum Clinical Research Inc entered the industry of Commercial Medical Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5419100, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Judy Magnum, President by calling (954) 452-8720 during business hours. You can also write to the business’ Single Location at 680 Nw 100th Terrace, Fort Lauderdale, Florida FL 33324. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Magnum Clinical Research Inc |
| Representative: | Judy Magnum, President |
| Place of Business: | 680 Nw 100th Terrace, Fort Lauderdale, FL 33324 |
| Contact Number: | (954) 452-8720 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 5419100 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2002 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Magnum Clinical Research Inc is a company operating from Broward, Florida providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 5419100 as Commercial Medical Research.
With a current employee count of 1 to 4, Magnum Clinical Research Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Judy Magnum, President at (954) 452-8720 for related queries, or to locate its Single Location using the coordinates 26.129561,-80.283384.
The Single Location can also be found at the street address 680 Nw 100th Terrace in Fort Lauderdale, Florida 33324 and can be engaged online through the company website at , the company Twitter , and Facebook page .